{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T21:20:06Z","timestamp":1777497606798,"version":"3.51.4"},"reference-count":4,"publisher":"American Psychiatric Association Publishing","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["AJP"],"published-print":{"date-parts":[[2002,7,1]]},"DOI":"10.1176\/appi.ajp.159.7.1244","type":"journal-article","created":{"date-parts":[[2002,10,11]],"date-time":"2002-10-11T18:30:25Z","timestamp":1034361025000},"page":"1244-1245","source":"Crossref","is-referenced-by-count":50,"title":["Galantamine for Treatment-Resistant Schizophrenia"],"prefix":"10.1176","volume":"159","author":[{"given":"TRINA B.","family":"ALLEN","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JOSEPH P.","family":"McEVOY","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"230","reference":[{"key":"R1597CIHDBIJH","doi-asserted-by":"crossref","unstructured":"Adler LE, Olincy A, Waldo M, Harris JG, Griffith J, Stevens K, Flach K, Nagamoto H, Bickford P, Leonard S, Freedman R: Schizophrenia, sensory gating, and nicotinic receptors. Schizophr Bull 1998; 24:189-202","DOI":"10.1093\/oxfordjournals.schbul.a033320"},{"key":"R1597CIHBHDEJ","doi-asserted-by":"crossref","unstructured":"Nagamoto HT, Adler LE, Hea RA, Griffith JM, McRae KA, Freedman R: Gating of auditory P50 in schizophrenia: unique effects of clozapine. Biol Psychiatry 1996; 40:181-188","DOI":"10.1016\/0006-3223(95)00371-1"},{"key":"R1597CIHBBJCH","doi-asserted-by":"crossref","unstructured":"Maelicke A, Albuquerque EX: Allosteric modulation of nicotinic acetylcholine receptors as a treatment strategy for Alzheimer\u2019s disease. Eur J Pharmacol 2000; 393:165-170","DOI":"10.1016\/S0014-2999(00)00093-5"},{"key":"R1597CIHBHADG","doi-asserted-by":"crossref","unstructured":"McEvoy JP, Freudenreich O, Wilson WH: Smoking and therapeutic response to clozapine in patients with schizophrenia. Biol Psychiatry 1999; 46:125-129","DOI":"10.1016\/S0006-3223(98)00377-1"}],"container-title":["American Journal of Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/psychiatryonline.org\/doi\/10.1176\/appi.ajp.159.7.1244","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,28]],"date-time":"2024-07-28T15:24:55Z","timestamp":1722180295000},"score":1,"resource":{"primary":{"URL":"https:\/\/psychiatryonline.org\/doi\/10.1176\/appi.ajp.159.7.1244"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,7,1]]},"references-count":4,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2002,7,1]]}},"alternative-id":["10.1176\/appi.ajp.159.7.1244"],"URL":"https:\/\/doi.org\/10.1176\/appi.ajp.159.7.1244","relation":{},"ISSN":["0002-953X","1535-7228"],"issn-type":[{"value":"0002-953X","type":"print"},{"value":"1535-7228","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,7,1]]}}}